Your browser doesn't support javascript.
loading
Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial.
Asrani, Sanjay; Robin, Alan L; Serle, Janet B; Lewis, Richard A; Usner, Dale W; Kopczynski, Casey C; Heah, Theresa.
Affiliation
  • Asrani S; Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: sanjay.asrani@duke.edu.
  • Robin AL; Wilmer Institute and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA; Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Serle JB; Icahn School of Medicine at Mount Sinai School, New York, New York, USA.
  • Lewis RA; Aerie Pharmaceuticals, Inc., Irvine, California, Bedminster, New Jersey, and Durham, North Carolina, USA; Sacramento Eye Consultants, Sacramento, California, USA.
  • Usner DW; Statistics & Data Corporation, Tempe, Arizona, USA.
  • Kopczynski CC; Aerie Pharmaceuticals, Inc., Irvine, California, Bedminster, New Jersey, and Durham, North Carolina, USA.
  • Heah T; Aerie Pharmaceuticals, Inc., Irvine, California, Bedminster, New Jersey, and Durham, North Carolina, USA.
Am J Ophthalmol ; 207: 248-257, 2019 11.
Article in En | MEDLINE | ID: mdl-31229466

Full text: 1 Database: MEDLINE Main subject: Benzoates / Glaucoma, Open-Angle / Beta-Alanine / Latanoprost / Intraocular Pressure Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Ophthalmol Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Benzoates / Glaucoma, Open-Angle / Beta-Alanine / Latanoprost / Intraocular Pressure Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Ophthalmol Year: 2019 Type: Article